Scholar Rock is a biopharmaceutical company that discovers, develops, and delivers life-changing therapies for people with serious diseases that have high unmet need. As a global leader in the biology of the transforming growth factor beta (TGFβ) superfamily of cell proteins and named for the visual resemblance of a scholar rock to protein structures, the clinical-stage company is focused on advancing innovative treatments where protein growth factors are fundamental. Over the past decade, the company has created a pipeline with the potential to advance the standard of care for neuromuscular disease, cardiometabolic disorders, cancer, and other conditions where growth factor-targeted drugs can play a transformational role.  Scholar Rock is the only company to show clinical proof of concept for a muscle-targeted treatment in spinal muscular atrophy (SMA). This commitment to unlocking fundamentally different therapeutic approaches is powered by broad application of a proprietary platform, which has developed novel monoclonal antibodies to modulate protein growth factors with extraordinary selectivity. By harnessing cutting-edge science in disease spaces that are historically under-addressed through traditional therapies, Scholar Rock works every day to create new possibilities for patients. Learn more about the company’s approach at and follow and on .
Summary of Position:
The Senior Director, Global Value & Access is a critical member of the Value & Access Leadership Team enabling the launch of apitegromab in spinal muscular atrophy (SMA) in Europe and other key ex-US markets. This role will lead the development and execution of Global market access strategies and tactics – including drug distribution, value proposition, pricing, health technology assessment, cost-effectiveness and budget impact modeling, early access programs, and payer engagement/negotiation approach. This is an opportunity for an entrepreneurial individual to help shape the trajectory of our first Commercial launch. This role works with urgency across the organization, collaborating with Marketing, Medical/HEOR, US Value & Access, local affiliates, and others to enable access to apitegromab for appropriate patients. A successful candidate will have a track record of launching rare disease drugs in Europe. This role is preferably based in the EU but other locations will be considered. Position Responsibilities:Build effective partnerships within Value & Access (US, European country affiliates) and across the organization – Medical/HEOR, Marketing, Finance, and others. Be a collaborative, strategic market access presence. Proactively identify and execute against opportunities to improve patient access to careCollaborate with Global Marketing and Insights team to generate ex-US access, payer, and pricing insights. Maintain up-to-date understanding of country-level reimbursement policies, pricing, access competitive intelligence, health technology assessment, and policy landscape (national, regional, local level, where appropriate). Define implications and actions for Scholar Rock and apitegromabLead ex-US Value and Access strategy, with ownership over: Global value proposition/dossier, Global pricing framework and bands, launch sequencing/timing and international price referencing, early access programs, distribution, evidence, cost-effectiveness and budget impact modeling, payer negotiation frameworksServe as the main point of contact for affiliate Value & Access teams. Drive collaboration and communication across countries. Partner with ex-US affiliate teams (e.g., Value & Access, Marketing, Medical, Policy, etc) to localize Global Value & Access strategies and ensure pricing is maintained within appropriate bands. Help define appropriate patient populations.  Continuously incorporate country-level insights into Global strategiesManage Global Value & Access vendors, resources, and budget. Develop impactful ex-US solutions and Global collateral for localization by affiliate Access teams. Proactively identify and address country-level needs Represent Value & Access on apitegromab Global teams and support financial and strategic planning processesEffectively communicate insights, strategies, voice of access customers, and implications to leadershipSupport pipeline and business development initiatives, as necessaryAbility to travel up to 30%, including to-and-from US/Europe on regular basisCandidate Requirements:Bachelors degree required. Advanced degrees in related healthcare fields a plusAt least 10 years’ experience in Global or EU-country-level Market Access with a deep understanding of evolving European access, coverage, and reimbursement landscapeTrack record of success in working cross-functionally to achieve objectives (Marketing, Medical, HEOR, Finance, Key Account Management/Sales, Policy/Advocacy, etc.)Strong understanding of Global market access strategy fundamentals: insights, strategy development, pricing & contracting, health technology assessments, early access programs, value proposition, impact on demand and GTNStrong understanding of ex-US national, regional, and local payers, decision making, processes/procedures, and data and reportingRare disease, neuromuscular, hospital-administered/infusion experience strongly preferredPre-launch experience at a biotechnology company preferredIndependent, proactive problem solver with strong written/PowerPoint and verbal communication skillsScholar Rock is an Equal Opportunity Employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.